PEStore

Buyout PE

Ancor Capital

Ancor Capital acquires controlling stakes in established, profitable businesses, from Dallas, Texas, USA. It states a focus on healthcare & life sciences, consumer & retail, industrials & manufacturing and energy & utilities.

Disclosed holdings22
Earliest stated investment2022
HeadquartersDallas, Texas, USA
Largest single fundNot stated

Stated investment criteria

What Ancor Capital says it buys

Read from Ancor Capital’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Enterprise value it states$25m to $150m1
EBITDA it states$5m to $15m1
OfficesDallas3
People listed on its team page162

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Ancor Capital to consider any particular business, and nothing on this page is represented as being for sale.

Regulatory record

How Ancor Capital is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusSEC registered
Regulatory assets under management$458m
Employees9
Private funds advised12 · $458m gross
SEC adviser numberCRD 210524

Portfolio

Disclosed holdings

Companies Ancor Capital lists on its own website. 3 carry a stated investment year. 1 has a recorded transaction against it in the deal archive.

CompanyInvestedYears heldRecorded transaction
Mid-West Textile20224
DISPLAYIT20233
Predictive Fitness20242
CEAR
Cearinc
Christensen Arms
Displayitinc
HealthTrackRx
ICON EV
Identity Group
Industrial Timber
LSC
Lscenv
Predictive
STATinMED
Stratus$225m 2022
Stratusneuro
Thesmartplay
VST
Vita 10
Vita10therapy
Vsthose

Compiled from Ancor Capital’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Ancor Capital?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.